Bio View Stock

Bio View Liabilities

The The Liabilities of Bio View (BIOV.TA) as of Sep 3, 2026 is 10.68 M ILS. In the previous year, The Liabilities was 14.65 M ILS — a change of -27.12% (lower).

Liabilities

10.68 MILS

YoY

-27.12%

Last updated:

In 2026, Bio View's total liabilities amounted to 10.68 M ILS, a -27.12% difference from the 14.65 M ILS total liabilities in the previous year.

The Bio View Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2017
11.26 M ILS
Jan 1, 2018
10.66 M ILS
Jan 1, 2019
12.03 M ILS
Jan 1, 2020
8.82 M ILS
Jan 1, 2021
12.86 M ILS
Jan 1, 2022
13.65 M ILS
Jan 1, 2023
14.65 M ILS
Jan 1, 2024
10.68 M ILS
The Bio View Liabilities history
YEARLiabilitiesYoY
10.68 MILS-27.12%
14.65 MILS+7.31%
13.65 MILS+6.18%
12.86 MILS+45.77%
8.82 MILS-26.70%
12.03 MILS+12.88%
10.66 MILS-5.30%
11.26 MILS+1.39%
11.10 MILS+6.85%
10.39 MILS-19.72%
12.94 MILS—
Access this data via the Eulerpool API
Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Bio View's Liabilities

Bio View's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bio View's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bio View's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bio View's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bio View’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bio View stock

The Liabilities of Bio View is 10.68 M ILS in 2026.

The Liabilities of Bio View changed from 14.65 M ILS to 10.68 M ILS, representing a -27.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Bio View since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Bio View historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Bio View

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bio View